442 - The development of LOXO-195, a second generation TRK kinase inhibitor that overcomes acquired resistance to 1st generation inhibitors observed in patients with TRK-fusion cancers
| Autor: | Blake, J., Kolakowski, G.R., Tuch, B., Ebata, K., Brandhuber, B., Winski, S., Bouhana, K., Nanda, N., Wu, W.I., Parker, A., Hamor, R., Larsen, P.D., Sullivan, F., DeWolf, W., Neitzel, N., Wollenberg, L., Andrews, S., Rothenberg, S.M. |
|---|---|
| Zdroj: | In European Journal of Cancer December 2016 69 Supplement 1:S144-S145 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect